LIGO Scientific Collaboration

Sickle Cell 101 Unveils Its Innovative Approach in Digital Advocacy for a 'Rare' Disorder Through Social Media

Retrieved on: 
Wednesday, February 1, 2023
Disease, Infection, Social media, Hospital, Education, Tissue, Empowerment, Cystic fibrosis, Sickle cell disease, Anti-transglutaminase antibodies, FDA, Degenerative disease, Patient, University, Research, LIGO Scientific Collaboration, Stroke, David Trimnel, Pain, Pharmaceutical industry, Sickle

San Jose, California--(Newsfile Corp. - February 1, 2023) - Sickle Cell 101 , a non-profit organization, is using an innovative approach of digital advocacy to provide education and patient focused research for sickle cell.

Key Points: 
  • San Jose, California--(Newsfile Corp. - February 1, 2023) - Sickle Cell 101 , a non-profit organization, is using an innovative approach of digital advocacy to provide education and patient focused research for sickle cell.
  • With a community that reaches millions on social media spread across 115 countries, Sickle Cell 101 has made a significant impact in promoting awareness of both sickle cell disease and sickle cell trait at the grassroots level through their digital platform, rich in educational and research resources.
  • "Our goal at Sickle Cell 101 is to function as a global platform to educate, engage, and empower an underserved community," says Cassandra Trimnell, Founder and Executive Director of Sickle Cell 101.
  • Sickle Cell 101 continues to seek and transform the outlook and experiences for individuals living with sickle cell disease through education and empowerment and spurring research in this area.

Bruce Gomes, PhD, Joins Applied BioMath, LLC, as Executive Director of Business Development & Scientific Collaborations

Retrieved on: 
Tuesday, June 28, 2022
National, View, Patient, CEO, Biotechnology, Biology, Research, Novartis, R, Pfizer, Quantitative biology, Industry, Applied Biomathematics, Berkeley, Pharmacology, Inflammation, NIH, LIGO Scientific Collaboration, Business development, LLC, University, Brandeis University, Biochemistry, Software, Doctor of Philosophy, Entrepreneurship, Machine learning, AstraZeneca, Johns Hopkins University, Multimedia, Medical device, Pharmaceutical industry, Management

CONCORD, Mass., June 28, 2022 /PRNewswire/ -- Applied BioMath ( www.appliedbiomath.com ), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), is proud to welcome Bruce Gomes, PhD, as Executive Director of Business Development & Scientific Collaborations.

Key Points: 
  • CONCORD, Mass., June 28, 2022 /PRNewswire/ -- Applied BioMath ( www.appliedbiomath.com ), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), is proud to welcome Bruce Gomes, PhD, as Executive Director of Business Development & Scientific Collaborations.
  • Prior to Applied BioMath, Bruce had a lengthy career in modeling and simulation, most recently as an Executive Director of Pharmacometrics at Novartis.
  • "We are honored to welcome someone of Bruce's caliber to our Applied BioMath Team," said John Burke, PhD, Co-Founder, President & CEO, Applied BioMath.
  • Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Labroots Announces 10th Annual Neuroscience Online Event Showcasing Dynamic Speakers

Retrieved on: 
Thursday, March 3, 2022
Industry, National, Disease, COVID-19, Nervous system, Trauma, Transcriptomics technologies, NIH, Neurodegeneration, News, Remyelination, Continuing education, Disability, Projection, PTP, Neuron, BRAIN Initiative, Neuroscience, NanoString Technologies, Ethics, Department, Stroke, Q&A, Depression, Degenerative disease, LIGO Scientific Collaboration, Invasive, BRAIN, CNS, Learning, CSPG, Labroots, Social media, Neurology, Science, Lists of diseases, Social, Conference, UCLA, Multiple system atrophy, DiaSorin, Therapy, Pharmaceutical industry, Medical device, Research, Philosophy, Brain

Join us as we review the latest scientific findings for emerging research, treatments, and therapies through collaborative efforts in the field.

Key Points: 
  • Join us as we review the latest scientific findings for emerging research, treatments, and therapies through collaborative efforts in the field.
  • I am excited to discuss how NervGen's technology modulates the response to CNS injury at Labroots' 10th Annual Neuroscience Virtual Conference."
  • By participating and attending this event, Continuing Education credit (1 per presentation) can be earned for a maximum of 40 credits.
  • Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities.

Violet Defense Teams Up With LSC Technologies to Expand the Reach of Its Patented Germ-Killing Lights

Retrieved on: 
Tuesday, January 15, 2019
Gravitational-wave astronomy, LIGO Scientific Collaboration, LSC

ORLANDO, Fla., Jan. 15, 2019 /PRNewswire/ -- Violet Defense and LSC Technologies announced today that they have partnered to bring Violet Defense's patented UV germ-killing technology to commercial and industrial markets nationally.

Key Points: 
  • ORLANDO, Fla., Jan. 15, 2019 /PRNewswire/ -- Violet Defense and LSC Technologies announced today that they have partnered to bring Violet Defense's patented UV germ-killing technology to commercial and industrial markets nationally.
  • LSC Technologies (LSC Tech) is a solutions-oriented technology company that is focused on developing custom installations for their clients.
  • "We are enthusiastic about this new partnership with LSC Tech for the next phase of our commercialization journey," said Terrance Berland, CEO for Violet Defense.
  • LSC Technologies (LSC Tech) brings innovative products to market in the lighting, controls, and security space.